ニュース
Eli Lilly shares dropped Thursday as Novo Nordisk notched a coverage win for its obesity drug, a sign of the competition in ...
The CDC posted an annual HIV report on Tuesday. It was slimmer than usual. The CDC said that a usual estimate of the ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...
While a new NIH policy introduces higher financial stakes and places compliance responsibility firmly with universities, it ...
The FDA’s decision to ban dyes and other synthetic substances often rests on the Delaney clause, a 49‑word law from 1958 that ...
Trump order targeting accreditation could shake up the small club of groups that set standards for medical schools and ...
Only 6.9% of people with drug-resistant infections in eight large, low- and middle-income countries received an appropriate ...
In a significant move, the NIH said it would reduce its reliance on animals in federally funded research and instead ...
Trump's canceled NIH grants and HHS layoffs threaten U.S. biomedical leadership, Collins says, as she calls for funding to be ...
For example, care technology company WellSky is careful to make sure it’s “keeping a human in the loop and not developing any ...
NIH has cancelled its participation in Safe to Sleep, a 30-year campaign to prevent babies from dying in their sleep ...
Novartis is buying Regulus for $800 million, picking up the biotech's experimental kidney drug that's based off a ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する